Andrea L. Cox

12.8k total citations · 2 hit papers
149 papers, 7.1k citations indexed

About

Andrea L. Cox is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Andrea L. Cox has authored 149 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hepatology, 59 papers in Epidemiology and 36 papers in Infectious Diseases. Recurrent topics in Andrea L. Cox's work include Hepatitis C virus research (75 papers), Hepatitis B Virus Studies (42 papers) and Liver Disease Diagnosis and Treatment (27 papers). Andrea L. Cox is often cited by papers focused on Hepatitis C virus research (75 papers), Hepatitis B Virus Studies (42 papers) and Liver Disease Diagnosis and Treatment (27 papers). Andrea L. Cox collaborates with scholars based in United States, Australia and Canada. Andrea L. Cox's co-authors include Stuart C. Ray, David L. Thomas, Donald F. Hunt, Jeffrey Shabanowitz, Víctor H. Engelhard, Justin R. Bailey, William O. Osburn, Alessandro Sette, Craig L. Slingluff and Drew M. Pardoll and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Andrea L. Cox

143 papers receiving 6.9k citations

Hit Papers

Identification of a Peptide Recognized by Five Melanoma-S... 1992 2026 2003 2014 1994 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea L. Cox United States 42 3.5k 3.0k 2.4k 1.4k 1.1k 149 7.1k
Krishna K. Murthy United States 30 3.1k 0.9× 3.0k 1.0× 1.4k 0.6× 947 0.7× 681 0.6× 73 5.6k
Kyong‐Mi Chang United States 39 7.6k 2.2× 7.1k 2.4× 2.5k 1.1× 816 0.6× 441 0.4× 114 10.6k
Aikichi Iwamoto Japan 43 1.1k 0.3× 2.3k 0.8× 1.6k 0.7× 1.5k 1.0× 519 0.5× 223 6.8k
Peter Balfe United Kingdom 40 3.1k 0.9× 3.0k 1.0× 867 0.4× 951 0.7× 888 0.8× 106 6.4k
Eleanor Barnes United Kingdom 54 4.4k 1.3× 5.0k 1.7× 1.6k 0.7× 1.2k 0.9× 605 0.6× 297 12.0k
Stephen M. Feinstone United States 44 5.5k 1.6× 4.8k 1.6× 686 0.3× 1.0k 0.7× 852 0.8× 91 7.7k
Michaela Lucas Australia 34 1.9k 0.5× 1.4k 0.5× 1.8k 0.7× 417 0.3× 334 0.3× 140 4.2k
Margaret James Koziel United States 42 5.1k 1.5× 4.4k 1.5× 1.4k 0.6× 327 0.2× 271 0.3× 98 6.8k
Michael Roggendorf Germany 45 3.5k 1.0× 5.0k 1.7× 1.5k 0.6× 684 0.5× 212 0.2× 225 7.0k
Robert Thimme Germany 62 8.4k 2.4× 7.5k 2.5× 7.0k 2.9× 1.7k 1.2× 651 0.6× 328 16.0k

Countries citing papers authored by Andrea L. Cox

Since Specialization
Citations

This map shows the geographic impact of Andrea L. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea L. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea L. Cox more than expected).

Fields of papers citing papers by Andrea L. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea L. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea L. Cox. The network helps show where Andrea L. Cox may publish in the future.

Co-authorship network of co-authors of Andrea L. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea L. Cox. A scholar is included among the top collaborators of Andrea L. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea L. Cox. Andrea L. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Girgis, Alexander A., Raffaello Cimbro, Ting Yang, et al.. (2025). Aberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease. Frontiers in Immunology. 16. 1607619–1607619.
2.
Hsieh, Leon L., Elizabeth A. Thompson, Weiqiang Zhou, et al.. (2025). SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19. Science Translational Medicine. 17(799). eadn7527–eadn7527. 1 indexed citations
3.
McAteer, John, Dorry L. Segev, Douglas Mogul, et al.. (2024). COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children. npj Vaccines. 9(1). 73–73. 3 indexed citations
4.
Andargie, T., Oren Gordon, Yi Wang, et al.. (2024). Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 2019. The Journal of Infectious Diseases. 230(2). e305–e317.
5.
Cox, Andrea L., Markus F. Stevens, Delordson Kallon, Atul Gupta, & Elizabeth M. White. (2023). Comparative evaluation of Luminex based assays for detection of SARS-CoV-2 antibodies in a transplantation laboratory. Journal of Immunological Methods. 517. 113472–113472. 7 indexed citations
6.
Villabona-Rueda, A.F., Samantha A. Whiteside, Sean Agbor-Enoh, et al.. (2023). Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients. The Journal of Heart and Lung Transplantation. 42(9). 1166–1174. 4 indexed citations
7.
Andargie, T., Tom Hill, Weiqiang Zhou, et al.. (2023). Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 133(21). 7 indexed citations
8.
Suwanmanee, San, Shristi Ghimire, Chenxu Guo, et al.. (2022). Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19. Viral Immunology. 35(3). 259–272. 4 indexed citations
9.
Skinner, Nicole, Andrew I. Flyak, Pamela J. Björkman, et al.. (2022). B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathogens. 18(1). e1010179–e1010179. 6 indexed citations
10.
Karaba, Andrew H., Weiqiang Zhou, Shuai Li, et al.. (2022). Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 76(3). e495–e498. 3 indexed citations
11.
Karaba, Andrew H., Weiqiang Zhou, Leon L. Hsieh, et al.. (2021). Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology. Clinical Infectious Diseases. 74(2). 254–262. 29 indexed citations
12.
Kandathil, Abraham J., Andrea L. Cox, Kimberly Page, et al.. (2021). Plasma virome and the risk of blood-borne infection in persons with substance use disorder. Nature Communications. 12(1). 6909–6909. 13 indexed citations
13.
Karaba, Andrew H., William A. Werbel, M. Veronica Dioverti, et al.. (2021). Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease. Transplant Infectious Disease. 23(4). e13682–e13682. 4 indexed citations
14.
Skinner, Nicole, Paul W. Blair, Han-Sol Park, et al.. (2021). Durable SARS-CoV-2 B cell immunity after mild or severe disease. Journal of Clinical Investigation. 131(7). 57 indexed citations
15.
Iversen, Jenny, Handan Wand, Judith I. Tsui, et al.. (2019). Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clinical Infectious Diseases. 70(1). 123–131. 10 indexed citations
16.
Massaccesi, Guido, Andrew I. Flyak, Madeleine C. Mankowski, et al.. (2019). Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. Journal of Clinical Investigation. 129(11). 4786–4796. 36 indexed citations
17.
Park, Benjamin V., Zachary T. Freeman, Ali Ghasemzadeh, et al.. (2016). TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer. Cancer Discovery. 6(12). 1366–1381. 218 indexed citations
18.
El–Diwany, Ramy, Lisa N. Wasilewski, Kenneth W. Witwer, et al.. (2015). Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release. Journal of Virology. 89(18). 9454–9464. 17 indexed citations
19.
Grebely, Jason, Gregory J. Dore, Maarten F. Schim van der Loeff, et al.. (2010). 1063 FACTORS ASSOCIATED WITH SPONTANEOUS CLEARANCE DURING ACUTE HEPATITIS C VIRUS INFECTION. Journal of Hepatology. 52. S411–S411. 2 indexed citations
20.
Dowd, Kimberly A., et al.. (2009). Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus. Gastroenterology. 136(7). 2377–2386. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026